Ken Getz is executive director of the Tufts Center for the Study of Drug Development (CSDD) and a research professor in the Tufts University School of Medicine. An internationally recognized expert in R&D and clinical trial management, his more than two decades of original research benchmarking R&D management practices have contributed to improvements in management strategy and execution. Getz is a board member of WCG Clinical, the parent company of FDAnews.